As NF-κB is a key regulator of inflammatory genes, there is ample evidence implicating it in IBD pathogenesis [39]; therefore, we monitored the inhibition of NF-κB by A. argyi treatment as well as its possible causes. Here, NFKB1 is linked to inflammatory bowel disease.